Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Acetylsalicylic-acid | hsa00020 | Citrate cycle (TCA cycle) | 4.06E-04 | 4 | Q9P2R7, P50213, P40925, O14521 | SUCLA2, IDH3A, MDH1, SDHD | More | | Acetylsalicylic-acid | hsa00030 | Pentose phosphate pathway | 2.82E-03 | 3 | P51854, P52209, P37837 | TKTL1, PGD, TALDO1 | More | | Acetylsalicylic-acid | hsa00040 | Pentose and glucuronate interconversions | 6.07E-03 | 1 | P15121 | AKR1B1 | More | | Acetylsalicylic-acid | hsa00051 | Fructose and mannose metabolism | 4.10E-04 | 3 | P15121, P19367, P08237 | AKR1B1, HK1, PFKM | More | | Acetylsalicylic-acid | hsa00052 | Galactose metabolism | 7.54E-05 | 5 | P06280, P08237, O43451, P15121, P19367 | GLA, PFKM, MGAM, AKR1B1, HK1 | More | | Acetylsalicylic-acid | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Acetylsalicylic-acid | hsa00100 | Steroid biosynthesis | 3.94E-02 | 1 | P35610 | SOAT1 | More | | Acetylsalicylic-acid | hsa00190 | Oxidative phosphorylation | 2.11E-04 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Acetylsalicylic-acid | hsa00220 | Arginine biosynthesis | 1.15E-06 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Acetylsalicylic-acid | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.40E-03 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Acetylsalicylic-acid | hsa00310 | Lysine degradation | 4.14E-02 | 1 | Q02809 | PLOD1 | More | | Acetylsalicylic-acid | hsa00350 | Tyrosine metabolism | 4.50E-02 | 1 | P00325 | ADH1B | More | | Acetylsalicylic-acid | hsa00471 | D-Glutamine and D-glutamate metabolism | 3.94E-02 | 1 | P49448 | GLUD2 | More | | Acetylsalicylic-acid | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | Acetylsalicylic-acid | hsa00500 | Starch and sucrose metabolism | 1.70E-05 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Acetylsalicylic-acid | hsa00512 | Mucin type O-glycan biosynthesis | 2.27E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Acetylsalicylic-acid | hsa00514 | Other types of O-glycan biosynthesis | 1.42E-02 | 2 | P15907, Q8N4A0 | ST6GAL1, GALNT4 | More | | Acetylsalicylic-acid | hsa00520 | Amino sugar and nucleotide sugar metabolism | 1.59E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Acetylsalicylic-acid | hsa00531 | Glycosaminoglycan degradation | 3.78E-02 | 1 | P15586 | GNS | More | | Acetylsalicylic-acid | hsa00561 | Glycerolipid metabolism | 1.51E-02 | 1 | P15121 | AKR1B1 | More | | Acetylsalicylic-acid | hsa00562 | Inositol phosphate metabolism | 4.55E-02 | 2 | P27987, P42338 | ITPKB, PIK3CB | More | | Acetylsalicylic-acid | hsa00564 | Glycerophospholipid metabolism | 3.56E-02 | 3 | P48651, Q9Y6K0, P35790 | PTDSS1, CEPT1, CHKA | More | | Acetylsalicylic-acid | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Acetylsalicylic-acid | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 7.10E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Acetylsalicylic-acid | hsa00620 | Pyruvate metabolism | 3.19E-02 | 2 | P40926, P14550 | MDH2, AKR1A1 | More | | Acetylsalicylic-acid | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Acetylsalicylic-acid | hsa00785 | Lipoic acid metabolism | 4.57E-02 | 1 | Q9Y234 | LIPT1 | More | | Acetylsalicylic-acid | hsa00790 | Folate biosynthesis | 9.61E-04 | 3 | Q92820, P07101, P15121 | GGH, TH, AKR1B1 | More | | Acetylsalicylic-acid | hsa00830 | Retinol metabolism | 1.63E-03 | 4 | P00325, P00352, Q9BPW9, O75911 | ADH1B, ALDH1A1, DHRS9, DHRS3 | More | | Acetylsalicylic-acid | hsa00910 | Nitrogen metabolism | 4.40E-03 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Acetylsalicylic-acid | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Acetylsalicylic-acid | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Acetylsalicylic-acid | hsa00983 | Drug metabolism - other enzymes | 1.45E-03 | 5 | P20839, P32320, P05164, Q16772, P09211 | IMPDH1, CDA, MPO, GSTA3, GSTP1 | More | | Acetylsalicylic-acid | hsa01100 | Metabolic pathways | 9.38E-06 | 52 | Q9NR34, Q9Y234, P35790, P05089, P21953, Q16772, P09211, Q9UJ14, P30041, P15104, P19367, P42338, P48426, P27987, P22557, P32320, P20839, P22748, P40926, P55809, P06280, Q16875, O43286, O43451, P53004, Q7KZN9, Q9Y6K0, P05186, P24666, P15121, P08237, O95861, Q9HCC0, P33121, Q9UHK6, Q86VZ5, P09917, P48651, P57054, Q9UNP4, Q9BX95, P32321, P49448, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q9BQB6, Q969G6, P14927 | MAN1C1, LIPT1, CHKA, ARG1, BCKDHB, GSTA3, GSTP1, GGTL3, PRDX6, GLUL, HK1, PIK3CB, PIP4K2A, ITPKB, ALAS2, CDA, IMPDH1, CA4, MDH2, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, BLVRA, COX15, CEPT1, ALPL, ACP1, AKR1B1, PFKM, BPNT1, MCCC2, ACSL1, AMACR, SGMS1, ALOX5, PTDSS1, PIGP, ST3GAL5, SGPP1, DCTD, GLUD2, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, VKORC1, RFK, UQCRB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.829 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P35790 | CHKA | Choline kinase alpha | -0.778 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P35790 | CHKA | Choline kinase alpha | -0.717 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P21953 | BCKDHB | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | 0.765 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.791 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.793 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P09211 | GSTP1 | Glutathione S-transferase P | 0.712 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.748 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P30041 | PRDX6 | Peroxiredoxin-6 | 0.893 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.75 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P15104 | GLUL | Glutamine synthetase | -0.819 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P19367 | HK1 | Hexokinase-1 | 0.777 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.733 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P48426 | PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0.745 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P27987 | ITPKB | Inositol-trisphosphate 3-kinase B | 0.745 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P22557 | ALAS2 | 5-aminolevulinate synthase, erythroid-specific, mitochondrial | 0.707 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 0.828 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | 0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P53004 | BLVRA | Biliverdin reductase A | 0.901 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q7KZN9 | COX15 | Cytochrome c oxidase assembly protein COX15 homolog | 0.764 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.802 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 0.732 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 1 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | 0.82 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | O95861 | BPNT1 | 3'(2'),5'-bisphosphate nucleotidase 1 | -0.702 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.704 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.795 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.736 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | -0.705 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P48651 | PTDSS1 | Phosphatidylserine synthase 1 | 0.802 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | 0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P32321 | DCTD | Deoxycytidylate deaminase | 0.79 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P49448 | GLUD2 | Glutamate dehydrogenase 2, mitochondrial | 0.74 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | -0.798 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P46976 | GYG1 | Glycogenin-1 | -0.82 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9BQB6 | VKORC1 | Vitamin K epoxide reductase complex subunit 1 | 0.731 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q969G6 | RFK | Riboflavin kinase | 0.797 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P14927 | UQCRB | Cytochrome b-c1 complex subunit 7 | 0.721 |
| Acetylsalicylic-acid | hsa01200 | Carbon metabolism | 8.75E-03 | 5 | P04406, P40925, O14521, Q9P2R7, Q02252 | GAPDH, MDH1, SDHD, SUCLA2, ALDH6A1 | More | | Acetylsalicylic-acid | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.40E-02 | 1 | P50213 | IDH3A | More | | Acetylsalicylic-acid | hsa01230 | Biosynthesis of amino acids | 3.91E-02 | 3 | P51854, Q99707, P50213 | TKTL1, MTR, IDH3A | More | | Acetylsalicylic-acid | hsa01240 | Biosynthesis of cofactors | 4.63E-02 | 3 | Q969G6, P22557, Q9Y234 | RFK, ALAS2, LIPT1 | More | | Acetylsalicylic-acid | hsa01522 | Endocrine resistance | 4.51E-02 | 2 | P04637, P42773 | TP53, CDKN2C | More | | Acetylsalicylic-acid | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Acetylsalicylic-acid | hsa01524 | Platinum drug resistance | 7.33E-04 | 5 | Q14790, P48023, Q16772, P09211, P31751 | CASP8, FASLG, GSTA3, GSTP1, AKT2 | More | | Acetylsalicylic-acid | hsa02010 | ABC transporters | 2.17E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | | Acetylsalicylic-acid | hsa03010 | Ribosome | 3.38E-03 | 8 | P62753, P62829, P46777, P62888, P61927, P61513, P36578, P50914 | RPS6, RPL23, RPL5, RPL30, RPL37, RPL37A, RPL4, RPL14 | More | | Acetylsalicylic-acid | hsa03013 | RNA transport | 4.49E-02 | 5 | P62826, Q9UBU9, P63279, P68104, Q14232 | RAN, NXF1, UBE2I, EEF1A1, EIF2B1 | More | | Acetylsalicylic-acid | hsa03020 | RNA polymerase | 4.09E-05 | 4 | P30876, P24928, P62487, Q9Y535 | POLR2B, POLR2A, POLR2G, POLR3H | More | | Acetylsalicylic-acid | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Acetylsalicylic-acid | hsa03040 | Spliceosome | 6.18E-04 | 12 | Q14562, O43143, P08579, O75940, O75494, Q07955, Q01130, Q13243, P11142, O95777, O43447, O43395 | DHX8, DHX15, SNRPB2, SMNDC1, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, LSM8, PPIH, PRPF3 | More | | Acetylsalicylic-acid | hsa04010 | MAPK signaling pathway | 4.93E-02 | 1 | Q16828 | DUSP6 | More | | Acetylsalicylic-acid | hsa04012 | ErbB signaling pathway | 3.15E-02 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | | Acetylsalicylic-acid | hsa04014 | Ras signaling pathway | 7.30E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Acetylsalicylic-acid | hsa04015 | Rap1 signaling pathway | 1.27E-04 | 6 | P07737, P25116, Q8TEU7, P31751, P0DP23, P08514 | PFN1, F2R, RAPGEF6, AKT2, CALM1, ITGA2B | More | | Acetylsalicylic-acid | hsa04020 | Calcium signaling pathway | 1.27E-03 | 9 | P27987, Q08828, P21796, P45880, Q13557, P19174, P0DP23, P05141, P51828 | ITPKB, ADCY1, VDAC1, VDAC2, CAMK2D, PLCG1, CALM1, SLC25A5, ADCY7 | More | | Acetylsalicylic-acid | hsa04022 | cGMP-PKG signaling pathway | 1.29E-07 | 14 | P24844, Q14814, Q99941, P18848, Q8WYR1, P31751, Q08828, P51828, P05141, P21796, P45880, Q15746, P0DP23, P01042 | MYL9, MEF2D, CREBL1, ATF4, PIK3R5, AKT2, ADCY1, ADCY7, SLC25A5, VDAC1, VDAC2, MYLK, CALM1, KNG1 | More | | Acetylsalicylic-acid | hsa04024 | cAMP signaling pathway | 1.19E-04 | 7 | Q08828, P51828, P31751, P0DP23, P48058, P25116, P24844 | ADCY1, ADCY7, AKT2, CALM1, GRIA4, F2R, MYL9 | More | | Acetylsalicylic-acid | hsa04060 | Cytokine-cytokine receptor interaction | 1.59E-04 | 13 | P14784, P27930, P14778, P26842, Q06643, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, P09341, P01730, Q93038 | IL2RB, IL1R2, IL1R1, CD27, LTB, IL10RA, IL21R, CXCR1, XCL2, XCL1, CXCL1, CD4, TNFRSF25 | More | | Acetylsalicylic-acid | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 7.72E-05 | 7 | Q8NHW4, P09341, P25024, P47992, Q9UBD3, Q13651, P14784 | CCL4L2, CXCL1, CXCR1, XCL1, XCL2, IL10RA, IL2RB | More | | Acetylsalicylic-acid | hsa04062 | Chemokine signaling pathway | 1.90E-06 | 11 | P25024, P09341, P47992, Q9UBD3, P07948, P42338, P63218, P50151, P43250, P49407, Q08881 | CXCR1, CXCL1, XCL1, XCL2, LYN, PIK3CB, GNG5, GNG10, GRK6, ARRB1, ITK | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P98066 | TNFAIP6 | Tumor necrosis factor-inducible gene 6 protein | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | 0.821 | P06239 | LCK | Tyrosine-protein kinase Lck | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.779 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.726 | P06239 | LCK | Tyrosine-protein kinase Lck | P09341 | CXCL1 | Growth-regulated alpha protein | -0.805 | P06239 | LCK | Tyrosine-protein kinase Lck | P47992 | XCL1 | Lymphotactin | 0.715 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P47992 | XCL1 | Lymphotactin | 0.703 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UBD3 | XCL2 | Cytokine SCM-1 beta | 0.715 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q9UBD3 | XCL2 | Cytokine SCM-1 beta | 0.703 | P98066 | TNFAIP6 | Tumor necrosis factor-inducible gene 6 protein | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.709 | P06239 | LCK | Tyrosine-protein kinase Lck | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.701 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.724 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.713 | P98066 | TNFAIP6 | Tumor necrosis factor-inducible gene 6 protein | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.766 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.733 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.791 | P98066 | TNFAIP6 | Tumor necrosis factor-inducible gene 6 protein | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.716 | P06239 | LCK | Tyrosine-protein kinase Lck | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.728 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | P98066 | TNFAIP6 | Tumor necrosis factor-inducible gene 6 protein | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.774 | P06239 | LCK | Tyrosine-protein kinase Lck | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.71 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.81 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.758 | P06239 | LCK | Tyrosine-protein kinase Lck | P43250 | GRK6 | G protein-coupled receptor kinase 6 | -0.702 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P49407 | ARRB1 | Beta-arrestin-1 | 0.803 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P49407 | ARRB1 | Beta-arrestin-1 | 0.807 | P06239 | LCK | Tyrosine-protein kinase Lck | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.774 |
| Acetylsalicylic-acid | hsa04064 | NF-kappa B signaling pathway | 1.83E-07 | 18 | P10415, O00463, P14778, P01584, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, Q06643, Q9NQC7 | BCL2, TRAF5, IL1R1, IL1B, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, LTB, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P06239 | LCK | Tyrosine-protein kinase Lck | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.718 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.739 | P06239 | LCK | Tyrosine-protein kinase Lck | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.724 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P06239 | LCK | Tyrosine-protein kinase Lck | P09341 | CXCL1 | Growth-regulated alpha protein | -0.805 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | P06239 | LCK | Tyrosine-protein kinase Lck | Q06643 | LTB | Lymphotoxin-beta | 0.846 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.753 |
| Acetylsalicylic-acid | hsa04068 | FoxO signaling pathway | 1.25E-02 | 2 | P48023, Q96BR1 | FASLG, SGK3 | More | | Acetylsalicylic-acid | hsa04070 | Phosphatidylinositol signaling system | 3.43E-05 | 9 | P19174, P0DP23, O14986, P23743, Q86XP1, Q16760, P48426, P27987, Q96DU7 | PLCG1, CALM1, PIP5K1B, DGKA, DGKH, DGKD, PIP4K2A, ITPKB, ITPKC | More | | Acetylsalicylic-acid | hsa04071 | Sphingolipid signaling pathway | 2.68E-05 | 8 | P21453, Q9H228, P01375, Q13510, Q13362, Q9BX95, P10415, Q9UQC2 | S1PR1, EDG8, TNF, ASAH1, PPP2R5C, SGPP1, BCL2, GAB2 | More | | Acetylsalicylic-acid | hsa04072 | Phospholipase D signaling pathway | 6.70E-05 | 7 | P31751, Q9UQC2, O14986, Q15438, Q08828, P51828, Q16760 | AKT2, GAB2, PIP5K1B, PSCD1, ADCY1, ADCY7, DGKD | More | | Acetylsalicylic-acid | hsa04080 | Neuroactive ligand-receptor interaction | 6.75E-04 | 8 | P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, ADRB2 | More | | Acetylsalicylic-acid | hsa04110 | Cell cycle | 3.31E-06 | 11 | P30260, P06493, O60566, O75293, P04637, P49918, P30304, P33981, P42773, P01106, Q13547 | CDC27, CDK1, BUB1B, GADD45B, TP53, CDKN1C, CDC25A, TTK, CDKN2C, MYC, HDAC1 | More | | Acetylsalicylic-acid | hsa04114 | Oocyte meiosis | 3.52E-05 | 13 | Q9Y6D9, P51812, Q02750, Q9UJX4, P30260, P0DP23, P16298, Q17RY0, Q08828, P51828, Q16539, Q13362, Q14738 | MAD1L1, RPS6KA3, MAP2K1, ANAPC5, CDC27, CALM1, PPP3CB, CPEB4, ADCY1, ADCY7, MAPK14, PPP2R5C, PPP2R5D | More | | Acetylsalicylic-acid | hsa04137 | Mitophagy - animal | 1.41E-03 | 3 | P67870, P19532, P18848 | CSNK2B, TFE3, ATF4 | More | | Acetylsalicylic-acid | hsa04140 | Autophagy - animal | 1.92E-03 | 9 | P31751, Q7L523, O75460, P22694, Q14643, P10415, Q04759, Q96GC9, Q8TEV9 | AKT2, RRAGA, ERN1, PRKACB, ITPR1, BCL2, PRKCQ, TMEM49, SMCR8 | More | | Acetylsalicylic-acid | hsa04141 | Protein processing in endoplasmic reticulum | 6.42E-03 | 8 | P18848, P30101, Q15437, Q15436, Q99941, P11142, P07900, P08238 | ATF4, PDIA3, SEC23B, SEC23A, CREBL1, HSPA8, HSP90AA1, HSP90AB1 | More | | Acetylsalicylic-acid | hsa04144 | Endocytosis | 3.45E-02 | 2 | P0DMV8, Q14161 | HSPA1A, GIT2 | More | | Acetylsalicylic-acid | hsa04145 | Phagosome | 2.76E-03 | 7 | O75015, Q15080, P05164, P78380, O60603, P35443, P13765 | FCGR3B, NCF4, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Acetylsalicylic-acid | hsa04151 | PI3K-Akt signaling pathway | 1.97E-03 | 15 | P62753, P04637, P27348, P07900, P08238, P62873, P63218, Q16363, P22105, P14784, Q99941, P18848, Q96BR1, P30279, P56279 | RPS6, TP53, YWHAQ, HSP90AA1, HSP90AB1, GNB1, GNG5, LAMA4, TNXB, IL2RB, CREBL1, ATF4, SGK3, CCND2, TCL1A | More | | Acetylsalicylic-acid | hsa04152 | AMPK signaling pathway | 3.76E-02 | 2 | Q96RR4, Q13362 | CAMKK2, PPP2R5C | More | | Acetylsalicylic-acid | hsa04210 | Apoptosis | 4.67E-04 | 11 | Q13315, P04637, P10415, O76075, Q14790, P48023, P24522, Q16548, P43234, Q14643, P42575 | ATM, TP53, BCL2, DFFB, CASP8, FASLG, GADD45A, BCL2A1, CTSO, ITPR1, CASP2 | More | | Acetylsalicylic-acid | hsa04211 | Longevity regulating pathway | 1.93E-03 | 5 | P31751, Q08828, P51828, P18848, Q96RR4 | AKT2, ADCY1, ADCY7, ATF4, CAMKK2 | More | | Acetylsalicylic-acid | hsa04213 | Longevity regulating pathway - multiple species | 4.21E-04 | 4 | P31751, Q08828, P51828, P0DMV8 | AKT2, ADCY1, ADCY7, HSPA1A | More | | Acetylsalicylic-acid | hsa04217 | Necroptosis | 1.12E-04 | 11 | Q9NQC7, P42224, P07900, P08238, P15104, P05141, P01584, Q13557, Q9H444, P21796, P45880 | CYLD, STAT1, HSP90AA1, HSP90AB1, GLUL, SLC25A5, IL1B, CAMK2D, CHMP4B, VDAC1, VDAC2 | More | | Acetylsalicylic-acid | hsa04218 | Cellular senescence | 3.65E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Acetylsalicylic-acid | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.65E-05 | 7 | Q08828, P51828, P31751, P18848, Q13362, Q14738, P0DP23 | ADCY1, ADCY7, AKT2, ATF4, PPP2R5C, PPP2R5D, CALM1 | More | | Acetylsalicylic-acid | hsa04270 | Vascular smooth muscle contraction | 4.65E-02 | 2 | Q15746, P24844 | MYLK, MYL9 | More | | Acetylsalicylic-acid | hsa04310 | Wnt signaling pathway | 1.79E-02 | 2 | P17612, P67870 | PRKACA, CSNK2B | More | | Acetylsalicylic-acid | hsa04330 | Notch signaling pathway | 2.29E-02 | 2 | Q92769, Q92830 | HDAC2, KAT2A | More | | Acetylsalicylic-acid | hsa04340 | Hedgehog signaling pathway | 2.39E-04 | 6 | P17612, P22694, Q13635, O43791, P30279, P10415 | PRKACA, PRKACB, PTCH1, SPOP, CCND2, BCL2 | More | | Acetylsalicylic-acid | hsa04360 | Axon guidance | 2.19E-02 | 3 | P42338, O14639, P24844 | PIK3CB, ABLIM1, MYL9 | More | | Acetylsalicylic-acid | hsa04370 | VEGF signaling pathway | 1.46E-03 | 4 | P16298, P31751, Q05397, Q02750 | PPP3CB, AKT2, PTK2, MAP2K1 | More | | Acetylsalicylic-acid | hsa04371 | Apelin signaling pathway | 2.48E-03 | 4 | P31751, Q08828, P51828, P0DP23 | AKT2, ADCY1, ADCY7, CALM1 | More | | Acetylsalicylic-acid | hsa04380 | Osteoclast differentiation | 2.94E-07 | 10 | Q9NQC7, Q9UQC2, Q16539, P23458, P31751, P01584, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, JAK1, AKT2, IL1B, IL1R1, FCGR3B, TNF, LILRA2 | More | | Acetylsalicylic-acid | hsa04510 | Focal adhesion | 3.11E-03 | 6 | P08514, Q15746, P24844, Q15942, P30281, Q9NQU5 | ITGA2B, MYLK, MYL9, ZYX, CCND3, PAK6 | More | | Acetylsalicylic-acid | hsa04512 | ECM-receptor interaction | 2.44E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Acetylsalicylic-acid | hsa04514 | Cell adhesion molecules | 4.65E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Acetylsalicylic-acid | hsa04530 | Tight junction | 7.42E-04 | 4 | Q8TEU7, O00501, Q14247, P24844 | RAPGEF6, CLDN5, CTTN, MYL9 | More | | Acetylsalicylic-acid | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 2.16E-02 | 2 | P04628, P40189 | WNT1, IL6ST | More | | Acetylsalicylic-acid | hsa04610 | Complement and coagulation cascades | 9.25E-06 | 3 | P25116, P0C0L4, P10909 | F2R, C4A, CLU | More | | Acetylsalicylic-acid | hsa04611 | Platelet activation | 1.07E-06 | 7 | P25116, Q9Y490, P08514, Q15746, Q8WYR1, P17612, P07359 | F2R, TLN1, ITGA2B, MYLK, PIK3R5, PRKACA, GP1BA | More | | Acetylsalicylic-acid | hsa04612 | Antigen processing and presentation | 4.24E-05 | 8 | P13765, P48382, P01730, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, CD4, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Acetylsalicylic-acid | hsa04613 | Neutrophil extracellular trap formation | 3.88E-04 | 16 | O60603, P05164, P08246, Q9UM07, P04908, Q93077, P68431, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC4; H2AC8, HIST1H2AC, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Acetylsalicylic-acid | hsa04620 | Toll-like receptor signaling pathway | 4.91E-04 | 3 | P01584, P31751, Q8NHW4 | IL1B, AKT2, CCL4L2 | More | | Acetylsalicylic-acid | hsa04621 | NOD-like receptor signaling pathway | 2.92E-02 | 3 | P01584, P07900, P43490 | IL1B, HSP90AA1, PBEF1 | More | | Acetylsalicylic-acid | hsa04622 | RIG-I-like receptor signaling pathway | 1.81E-02 | 1 | Q9NQC7 | CYLD | More | | Acetylsalicylic-acid | hsa04623 | Cytosolic DNA-sensing pathway | 2.21E-04 | 3 | P01584, Q9Y535, Q8NHW4 | IL1B, POLR3H, CCL4L2 | More | | Acetylsalicylic-acid | hsa04625 | C-type lectin receptor signaling pathway | 7.60E-06 | 8 | Q9ULY5, P01584, Q9NQC7, P20749, P01375, P31751, P0DP23, Q16539 | CLEC4E, IL1B, CYLD, BCL3, TNF, AKT2, CALM1, MAPK14 | More | | Acetylsalicylic-acid | hsa04630 | JAK-STAT signaling pathway | 3.25E-03 | 6 | P31751, O75925, P23458, P40189, Q13651, Q06124 | AKT2, PIAS1, JAK1, IL6ST, IL10RA, PTPN11 | More | | Acetylsalicylic-acid | hsa04640 | Hematopoietic cell lineage | 1.44E-07 | 13 | P13612, P14778, P27930, P11215, P20023, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765 | ITGA4, IL1R1, IL1R2, ITGAM, CR2, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB | More | | Acetylsalicylic-acid | hsa04650 | Natural killer cell mediated cytotoxicity | 4.83E-06 | 10 | P01375, P06239, O60880, P20963, Q13241, P26718, O14931, O75015, P26717, P26715 | TNF, LCK, SH2D1A, CD247, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | | Acetylsalicylic-acid | hsa04657 | IL-17 signaling pathway | 2.64E-06 | 14 | P25963, P07900, P08238, O00463, Q07955, Q16539, P49841, P09341, P14780, P04141, P80188, P01375, P06702, P01584 | NFKBIA, HSP90AA1, HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL1, MMP9, CSF2, LCN2, TNF, S100A9, IL1B | More | | Acetylsalicylic-acid | hsa04658 | Th1 and Th2 cell differentiation | 3.17E-17 | 14 | Q04759, P07766, P20963, P09693, P19174, P01730, P06239, P42224, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, CD4, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q04759 | PRKCQ | Protein kinase C theta type | 0.755 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q04759 | PRKCQ | Protein kinase C theta type | 0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P01106 | MYC | Myc proto-oncogene protein | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.837 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.855 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.776 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.895 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P01106 | MYC | Myc proto-oncogene protein | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.834 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.762 | P01106 | MYC | Myc proto-oncogene protein | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.812 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.708 | P01106 | MYC | Myc proto-oncogene protein | P06239 | LCK | Tyrosine-protein kinase Lck | 0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.767 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.867 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.75 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.928 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.715 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.852 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.795 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.753 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.76 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.85 | P30304 | CDC25A | M-phase inducer phosphatase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.721 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.82 |
| Acetylsalicylic-acid | hsa04659 | Th17 cell differentiation | 1.39E-12 | 16 | Q04759, P19174, P01730, P06239, P42224, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07900, P08238, P07766, P09693, P20963 | PRKCQ, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, HSP90AA1, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q04759 | PRKCQ | Protein kinase C theta type | 0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P01106 | MYC | Myc proto-oncogene protein | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.834 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.762 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.936 | P01106 | MYC | Myc proto-oncogene protein | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.812 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.708 | P01106 | MYC | Myc proto-oncogene protein | P06239 | LCK | Tyrosine-protein kinase Lck | 0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.767 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.867 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.75 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.754 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.795 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.831 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.753 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.746 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.841 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.709 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.876 | P01106 | MYC | Myc proto-oncogene protein | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.837 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.748 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.855 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.895 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 |
| Acetylsalicylic-acid | hsa04660 | T cell receptor signaling pathway | 1.77E-09 | 16 | P01375, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P16333, P07766, P20963, P09693, P01730, P01732, Q13191, P06239 | TNF, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, NCK1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01375 | TNF | Tumor necrosis factor | -0.813 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q04759 | PRKCQ | Protein kinase C theta type | 0.755 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q04759 | PRKCQ | Protein kinase C theta type | 0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.791 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.754 | P06239 | LCK | Tyrosine-protein kinase Lck | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.774 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.873 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.762 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P16333 | NCK1 | Cytoplasmic protein NCK1 | -0.781 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.855 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.776 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.895 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.708 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.812 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.744 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.714 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.734 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.738 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.767 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.867 |
| Acetylsalicylic-acid | hsa04662 | B cell receptor signaling pathway | 4.94E-08 | 6 | P31751, P42338, P60033, P07948, P21854, Q8N149 | AKT2, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Acetylsalicylic-acid | hsa04664 | Fc epsilon RI signaling pathway | 6.45E-06 | 7 | P01375, P31751, Q16539, P42338, Q9UQC2, P07948, P09917 | TNF, AKT2, MAPK14, PIK3CB, GAB2, LYN, ALOX5 | More | | Acetylsalicylic-acid | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Acetylsalicylic-acid | hsa04670 | Leukocyte transendothelial migration | 4.66E-02 | 4 | P11215, P60709, P19174, P12814 | ITGAM, ACTB, PLCG1, ACTN1 | More | | Acetylsalicylic-acid | hsa04710 | Circadian rhythm | 4.40E-02 | 1 | O15516 | CLOCK | More | | Acetylsalicylic-acid | hsa04713 | Circadian entrainment | 5.62E-03 | 6 | P0DP23, Q13557, P62873, P63218, Q08828, P51828 | CALM1, CAMK2D, GNB1, GNG5, ADCY1, ADCY7 | More | | Acetylsalicylic-acid | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Acetylsalicylic-acid | hsa04720 | Long-term potentiation | 5.63E-04 | 7 | P16298, P0DP23, Q15418, P51812, P18848, Q08828, Q02750 | PPP3CB, CALM1, RPS6KA1, RPS6KA3, ATF4, ADCY1, MAP2K1 | More | | Acetylsalicylic-acid | hsa04721 | Synaptic vesicle cycle | 1.80E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Acetylsalicylic-acid | hsa04722 | Neurotrophin signaling pathway | 2.83E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Acetylsalicylic-acid | hsa04724 | Glutamatergic synapse | 2.87E-04 | 6 | P48058, P43003, P63218, P50151, P15104, Q9NSB8 | GRIA4, SLC1A3, GNG5, GNG10, GLUL, HOMER2 | More | | Acetylsalicylic-acid | hsa04725 | Cholinergic synapse | 1.61E-04 | 9 | Q08828, P51828, P62873, P63218, P50151, P18848, Q13557, P42338, P31751 | ADCY1, ADCY7, GNB1, GNG5, GNG10, ATF4, CAMK2D, PIK3CB, AKT2 | More | | Acetylsalicylic-acid | hsa04727 | GABAergic synapse | 3.21E-05 | 6 | P51828, P62873, P63218, P50151, P15104, P46459 | ADCY7, GNB1, GNG5, GNG10, GLUL, NSF | More | | Acetylsalicylic-acid | hsa04728 | Dopaminergic synapse | 4.53E-05 | 9 | P62873, P63218, P31751, Q99941, P18848, Q13557, Q13362, Q14738, P0DP23 | GNB1, GNG5, AKT2, CREBL1, ATF4, CAMK2D, PPP2R5C, PPP2R5D, CALM1 | More | | Acetylsalicylic-acid | hsa04740 | Olfactory transduction | 1.44E-03 | 3 | P62873, Q13557, P0DP23 | GNB1, CAMK2D, CALM1 | More | | Acetylsalicylic-acid | hsa04742 | Taste transduction | 3.91E-02 | 1 | P17612 | PRKACA | More | | Acetylsalicylic-acid | hsa04744 | Phototransduction | 2.13E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Acetylsalicylic-acid | hsa04750 | Inflammatory mediator regulation of TRP channels | 2.81E-05 | 11 | P14778, P01584, Q08828, P51828, Q13557, P19174, P42338, P24723, Q04759, P0DP23, P01042 | IL1R1, IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM1, KNG1 | More | | Acetylsalicylic-acid | hsa04810 | Regulation of actin cytoskeleton | 4.36E-04 | 5 | P07737, P24844, Q15746, P08514, P25116 | PFN1, MYL9, MYLK, ITGA2B, F2R | More | | Acetylsalicylic-acid | hsa04910 | Insulin signaling pathway | 9.82E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | | Acetylsalicylic-acid | hsa04911 | Insulin secretion | 2.40E-02 | 3 | Q08828, P51828, P18848 | ADCY1, ADCY7, ATF4 | More | | Acetylsalicylic-acid | hsa04912 | GnRH signaling pathway | 1.39E-02 | 4 | Q08828, P51828, P18848, P0DP23 | ADCY1, ADCY7, ATF4, CALM1 | More | | Acetylsalicylic-acid | hsa04914 | Progesterone-mediated oocyte maturation | 6.28E-04 | 7 | Q17RY0, Q9UJX4, P30260, Q9Y6D9, P51812, Q02750, Q16539 | CPEB4, ANAPC5, CDC27, MAD1L1, RPS6KA3, MAP2K1, MAPK14 | More | | Acetylsalicylic-acid | hsa04915 | Estrogen signaling pathway | 2.23E-06 | 11 | Q99941, P18848, Q08828, P51828, P31751, P07900, P08238, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ATF4, ADCY1, ADCY7, AKT2, HSP90AA1, HSP90AB1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Acetylsalicylic-acid | hsa04916 | Melanogenesis | 4.69E-03 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | | Acetylsalicylic-acid | hsa04917 | Prolactin signaling pathway | 2.41E-02 | 1 | P31751 | AKT2 | More | | Acetylsalicylic-acid | hsa04918 | Thyroid hormone synthesis | 4.48E-02 | 2 | P18848, P05543 | ATF4, SERPINA7 | More | | Acetylsalicylic-acid | hsa04920 | Adipocytokine signaling pathway | 3.82E-04 | 3 | Q06124, Q9Y478, P31751 | PTPN11, PRKAB1, AKT2 | More | | Acetylsalicylic-acid | hsa04921 | Oxytocin signaling pathway | 6.37E-03 | 3 | Q15746, P24844, Q8WYR1 | MYLK, MYL9, PIK3R5 | More | | Acetylsalicylic-acid | hsa04922 | Glucagon signaling pathway | 3.14E-03 | 6 | P22694, P06737, Q12778, P31751, P0DP23, Q14643 | PRKACB, PYGL, FOXO1, AKT2, CALM1, ITPR1 | More | | Acetylsalicylic-acid | hsa04923 | Regulation of lipolysis in adipocytes | 6.65E-04 | 3 | Q08828, P51828, P31751 | ADCY1, ADCY7, AKT2 | More | | Acetylsalicylic-acid | hsa04924 | Renin secretion | 9.33E-05 | 4 | P22694, P07550, Q14643, P0DP23 | PRKACB, ADRB2, ITPR1, CALM1 | More | | Acetylsalicylic-acid | hsa04925 | Aldosterone synthesis and secretion | 9.58E-04 | 6 | Q99941, P18848, Q08828, P51828, P0DP23, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, CALM1, CAMK2D | More | | Acetylsalicylic-acid | hsa04926 | Relaxin signaling pathway | 1.80E-03 | 7 | P31751, P42338, P50151, P18848, Q08828, P51828, P49407 | AKT2, PIK3CB, GNG10, ATF4, ADCY1, ADCY7, ARRB1 | More | | Acetylsalicylic-acid | hsa04927 | Cortisol synthesis and secretion | 1.59E-02 | 3 | P18848, Q08828, P51828 | ATF4, ADCY1, ADCY7 | More | | Acetylsalicylic-acid | hsa04928 | Parathyroid hormone synthesis, secretion and action | 4.23E-02 | 4 | Q14643, P22694, P23771, P10415 | ITPR1, PRKACB, GATA3, BCL2 | More | | Acetylsalicylic-acid | hsa04929 | GnRH secretion | 6.70E-04 | 3 | P42338, P31751, P49407 | PIK3CB, AKT2, ARRB1 | More | | Acetylsalicylic-acid | hsa04931 | Insulin resistance | 1.48E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | | Acetylsalicylic-acid | hsa04932 | Non-alcoholic fatty liver disease | 7.19E-06 | 12 | P31751, P49841, Q14790, P18848, P48023, O75460, P01584, P12074, O15239, Q16718, O95298, O14521 | AKT2, GSK3B, CASP8, ATF4, FASLG, ERN1, IL1B, COX6A1, NDUFA1, NDUFA5, NDUFC2, SDHD | More | | Acetylsalicylic-acid | hsa04934 | Cushing syndrome | 4.54E-02 | 3 | P18848, Q08828, P51828 | ATF4, ADCY1, ADCY7 | More | | Acetylsalicylic-acid | hsa04935 | Growth hormone synthesis, secretion and action | 1.88E-02 | 4 | Q08828, P51828, P18848, P31751 | ADCY1, ADCY7, ATF4, AKT2 | More | | Acetylsalicylic-acid | hsa04940 | Type I diabetes mellitus | 1.55E-02 | 3 | P10747, P13765, P01375 | CD28, HLA-DOB, TNF | More | | Acetylsalicylic-acid | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.40E-02 | 1 | O00141 | SGK | More | | Acetylsalicylic-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Acetylsalicylic-acid | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Acetylsalicylic-acid | hsa04970 | Salivary secretion | 1.57E-04 | 7 | P07550, Q08828, P51828, P22694, Q14643, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, ITPR1, CALM1, CAMP | More | | Acetylsalicylic-acid | hsa04971 | Gastric acid secretion | 4.91E-04 | 4 | Q08828, P51828, P15311, P0DP23 | ADCY1, ADCY7, VIL2, CALM1 | More | | Acetylsalicylic-acid | hsa04973 | Carbohydrate digestion and absorption | 9.61E-04 | 3 | O43451, P42338, P31751 | MGAM, PIK3CB, AKT2 | More | | Acetylsalicylic-acid | hsa04976 | Bile secretion | 9.77E-04 | 5 | O43315, Q08828, P51828, P08183, Q14032 | AQP9, ADCY1, ADCY7, ABCB1, BAAT | More | | Acetylsalicylic-acid | hsa05010 | Alzheimer disease | 1.60E-05 | 16 | O95298, P19404, P13073, Q00535, O75460, P0DP23, P01584, P18848, Q71U36, Q13509, P67870, P31751, P05141, P21796, P45880, P28070 | NDUFC2, NDUFV2, COX4I1, CDK5, ERN1, CALM1, IL1B, ATF4, TUBA1A, TUBB3, CSNK2B, AKT2, SLC25A5, VDAC1, VDAC2, PSMB4 | More | | Acetylsalicylic-acid | hsa05012 | Parkinson disease | 6.70E-04 | 11 | P19404, P13073, P05141, P21796, P45880, P18848, P19174, P0DP23, Q13557, Q71U36, Q13509 | NDUFV2, COX4I1, SLC25A5, VDAC1, VDAC2, ATF4, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3 | More | | Acetylsalicylic-acid | hsa05014 | Amyotrophic lateral sclerosis | 4.20E-02 | 5 | Q71U36, Q13148, P21796, P43243, P84103 | TUBA1A, TARDBP, VDAC1, MATR3, SFRS3 | More | | Acetylsalicylic-acid | hsa05016 | Huntington disease | 6.51E-04 | 14 | O95298, P19404, P13073, Q13547, P24928, P30876, P62487, P05141, P21796, P45880, O75460, Q71U36, Q13509, P28070 | NDUFC2, NDUFV2, COX4I1, HDAC1, POLR2A, POLR2B, POLR2G, SLC25A5, VDAC1, VDAC2, ERN1, TUBA1A, TUBB3, PSMB4 | More | | Acetylsalicylic-acid | hsa05017 | Spinocerebellar ataxia | 3.94E-02 | 4 | O75460, P31751, P28070, P05141 | ERN1, AKT2, PSMB4, SLC25A5 | More | | Acetylsalicylic-acid | hsa05020 | Prion disease | 1.99E-04 | 15 | P11142, Q16718, P19404, O14521, P13073, P18848, P05141, P21796, P45880, Q71U36, Q13509, P49841, P67870, Q99941, Q16539 | HSPA8, NDUFA5, NDUFV2, SDHD, COX4I1, ATF4, SLC25A5, VDAC1, VDAC2, TUBA1A, TUBB3, GSK3B, CSNK2B, CREBL1, MAPK14 | More | | Acetylsalicylic-acid | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.34E-05 | 24 | Q71U36, Q13509, P49841, Q16718, O95298, P19404, O14521, P13073, Q8TEV9, P21796, O75460, P18848, Q13561, P19174, P05141, P45880, P20333, Q16539, Q00535, P01584, Q08752, P0DP23, Q13557, P28070 | TUBA1A, TUBB3, GSK3B, NDUFA5, NDUFC2, NDUFV2, SDHD, COX4I1, SMCR8, VDAC1, ERN1, ATF4, DCTN2, PLCG1, SLC25A5, VDAC2, TNFRSF1B, MAPK14, CDK5, IL1B, PPID, CALM1, CAMK2D, PSMB4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q71U36 | TUBA1A | Tubulin alpha-1A chain | -0.76 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q13509 | TUBB3 | Tubulin beta-3 chain | 0.724 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.778 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P19404 | NDUFV2 | NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | 0.721 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.712 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8TEV9 | SMCR8 | Guanine nucleotide exchange protein SMCR8 | 0.807 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.741 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.734 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.83 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q13561 | DCTN2 | Dynactin subunit 2 | -0.771 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.936 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.724 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.779 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.803 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.702 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 0.726 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.859 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P0DP23 | CALM1 | Calmodulin-1 | 0.804 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.745 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.736 |
| Acetylsalicylic-acid | hsa05030 | Cocaine addiction | 4.19E-02 | 1 | Q00535 | CDK5 | More | | Acetylsalicylic-acid | hsa05031 | Amphetamine addiction | 1.32E-03 | 5 | P0DP23, Q13557, Q99941, P18848, Q13547 | CALM1, CAMK2D, CREBL1, ATF4, HDAC1 | More | | Acetylsalicylic-acid | hsa05034 | Alcoholism | 1.27E-02 | 7 | Q99941, P18848, Q13547, P0DP23, P62873, P63218, O60814 | CREBL1, ATF4, HDAC1, CALM1, GNB1, GNG5, H2BC12 | More | | Acetylsalicylic-acid | hsa05100 | Bacterial invasion of epithelial cells | 4.54E-02 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | | Acetylsalicylic-acid | hsa05110 | Vibrio cholerae infection | 2.11E-03 | 2 | Q99437, P17612 | ATP6V0B, PRKACA | More | | Acetylsalicylic-acid | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.30E-03 | 6 | Q16539, Q99437, P09341, P25024, P25025, P41240 | MAPK14, ATP6V0B, CXCL1, CXCR1, CXCR2, CSK | More | | Acetylsalicylic-acid | hsa05130 | Pathogenic Escherichia coli infection | 2.49E-03 | 6 | Q14247, O00501, P25116, Q15438, P35579, P55061 | CTTN, CLDN5, F2R, PSCD1, MYH9, TEGT | More | | Acetylsalicylic-acid | hsa05131 | Shigellosis | 1.05E-02 | 7 | Q9NQL2, P0CG47, Q14141, Q96JJ3, Q05397, Q13315, P07737 | RRAGD, UBB, SEPT6, ELMO2, PTK2, ATM, PFN1 | More | | Acetylsalicylic-acid | hsa05133 | Pertussis | 2.70E-03 | 2 | P10145, P0C0L4 | IL8, C4A | More | | Acetylsalicylic-acid | hsa05134 | Legionellosis | 3.40E-03 | 5 | P11215, P68104, P0DMV8, P11142, P19875 | ITGAM, EEF1A1, HSPA1A, HSPA8, CXCL2 | More | | Acetylsalicylic-acid | hsa05135 | Yersinia infection | 1.82E-02 | 4 | P60709, P06239, P19174, P01730 | ACTB, LCK, PLCG1, CD4 | More | | Acetylsalicylic-acid | hsa05140 | Leishmaniasis | 4.21E-04 | 9 | O75015, P14598, P13765, O60603, P25963, P29350, P49006, Q16539, Q15080 | FCGR3B, NCF1, HLA-DOB, TLR2, NFKBIA, PTPN6, MARCKSL1, MAPK14, NCF4 | More | | Acetylsalicylic-acid | hsa05142 | Chagas disease | 2.70E-02 | 2 | P48023, Q14790 | FASLG, CASP8 | More | | Acetylsalicylic-acid | hsa05143 | African trypanosomiasis | 1.00E-03 | 2 | P69905, P68871 | HBA2, HBB | More | | Acetylsalicylic-acid | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Acetylsalicylic-acid | hsa05145 | Toxoplasmosis | 6.35E-03 | 2 | P23458, P0DMV8 | JAK1, HSPA1A | More | | Acetylsalicylic-acid | hsa05146 | Amoebiasis | 1.99E-07 | 11 | Q13751, P09341, P14778, P27930, P01375, O60603, P42338, P05089, P22694, P12814, P08311 | LAMB3, CXCL1, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ARG1, PRKACB, ACTN1, CTSG | More | | Acetylsalicylic-acid | hsa05150 | Staphylococcus aureus infection | 2.66E-03 | 6 | P21730, P21462, O75015, P13765, P12838, P49913 | C5AR1, FPR1, FCGR3B, HLA-DOB, DEFA4, CAMP | More | | Acetylsalicylic-acid | hsa05152 | Tuberculosis | 9.92E-03 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | | Acetylsalicylic-acid | hsa05162 | Measles | 5.50E-04 | 6 | P23458, P0DMV8, P11142, Q13191, P30279, O43318 | JAK1, HSPA1A, HSPA8, CBLB, CCND2, MAP3K7 | More | | Acetylsalicylic-acid | hsa05163 | Human cytomegalovirus infection | 1.70E-06 | 17 | P31751, P01375, Q14643, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, Q13651, P25025, Q16539, P18848, P04637, O00463 | AKT2, TNF, ITPR1, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, MAPK14, ATF4, TP53, TRAF5 | More | | Acetylsalicylic-acid | hsa05164 | Influenza A | 4.49E-02 | 5 | P31751, P01584, P23458, P05141, Q9UBU9 | AKT2, IL1B, JAK1, SLC25A5, NXF1 | More | | Acetylsalicylic-acid | hsa05166 | Human T-cell leukemia virus 1 infection | 3.90E-02 | 7 | P23458, P05141, P62826, Q08828, P51828, P18848, P31751 | JAK1, SLC25A5, RAN, ADCY1, ADCY7, ATF4, AKT2 | More | | Acetylsalicylic-acid | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.59E-03 | 8 | P31751, P42224, P62873, P63218, P19875, P19174, P07948, P0DP23 | AKT2, STAT1, GNB1, GNG5, CXCL2, PLCG1, LYN, CALM1 | More | | Acetylsalicylic-acid | hsa05169 | Epstein-Barr virus infection | 7.49E-05 | 16 | P13765, P01106, Q13547, Q92769, O00463, O43318, P07948, P30101, Q13761, P24522, O75293, P30279, P42224, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, HDAC2, TRAF5, MAP3K7, LYN, PDIA3, RUNX3, GADD45A, GADD45B, CCND2, STAT1, CD3E, CD3G, CD247 | More | | Acetylsalicylic-acid | hsa05170 | Human immunodeficiency virus 1 infection | 3.76E-03 | 7 | P31751, Q02750, P62879, P16298, P0DP23, Q05397, Q13315 | AKT2, MAP2K1, GNB2, PPP3CB, CALM1, PTK2, ATM | More | | Acetylsalicylic-acid | hsa05171 | Coronavirus disease - COVID-19 | 3.18E-03 | 7 | P01584, P62753, P36578, P62888, P61927, P61513, P62829 | IL1B, RPS6, RPL4, RPL30, RPL37, RPL37A, RPL23 | More | | Acetylsalicylic-acid | hsa05200 | Pathways in cancer | 3.06E-04 | 18 | Q16363, P07900, P08238, P42224, P19174, P43246, P20585, Q13547, P30279, P31751, P62873, P63218, P78417, O75293, P0DP23, Q13557, P14784, P01042 | LAMA4, HSP90AA1, HSP90AB1, STAT1, PLCG1, MSH2, MSH3, HDAC1, CCND2, AKT2, GNB1, GNG5, GSTO1, GADD45B, CALM1, CAMK2D, IL2RB, KNG1 | More | | Acetylsalicylic-acid | hsa05202 | Transcriptional misregulation in cancer | 1.73E-05 | 14 | Q12778, Q13315, P41732, P14780, Q15744, Q16548, O15550, P35226, P05164, P12838, P08246, Q16828, Q9C0K0, P24522 | FOXO1, ATM, TSPAN7, MMP9, CEBPE, BCL2A1, UTX, BMI1, MPO, DEFA4, ELA2, DUSP6, BCL11B, GADD45A | More | | Acetylsalicylic-acid | hsa05203 | Viral carcinogenesis | 2.47E-04 | 13 | Q12933, Q99941, P18848, P42229, P06746, P07948, P30279, P27348, P29083, Q7KZF4, Q13547, Q15283, O60814 | TRAF2, CREBL1, ATF4, STAT5A, POLB, LYN, CCND2, YWHAQ, GTF2E1, SND1, HDAC1, RASA2, H2BC12 | More | | Acetylsalicylic-acid | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Acetylsalicylic-acid | hsa05211 | Renal cell carcinoma | 4.78E-02 | 1 | P31751 | AKT2 | More | | Acetylsalicylic-acid | hsa05212 | Pancreatic cancer | 4.69E-03 | 3 | P31751, Q15311, P23458 | AKT2, RALBP1, JAK1 | More | | Acetylsalicylic-acid | hsa05213 | Endometrial cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | | Acetylsalicylic-acid | hsa05214 | Glioma | 5.03E-04 | 5 | P0DP23, Q13557, P31751, P19174, O75293 | CALM1, CAMK2D, AKT2, PLCG1, GADD45B | More | | Acetylsalicylic-acid | hsa05216 | Thyroid cancer | 2.72E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Acetylsalicylic-acid | hsa05217 | Basal cell carcinoma | 4.79E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Acetylsalicylic-acid | hsa05218 | Melanoma | 2.78E-03 | 3 | P04637, P31751, P24522 | TP53, AKT2, GADD45A | More | | Acetylsalicylic-acid | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Acetylsalicylic-acid | hsa05220 | Chronic myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | | Acetylsalicylic-acid | hsa05221 | Acute myeloid leukemia | 1.25E-03 | 2 | P31751, Q16828 | AKT2, DUSP6 | More | | Acetylsalicylic-acid | hsa05222 | Small cell lung cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Acetylsalicylic-acid | hsa05223 | Non-small cell lung cancer | 3.31E-03 | 4 | P31751, P19174, Q9HC35, O75293 | AKT2, PLCG1, EML4, GADD45B | More | | Acetylsalicylic-acid | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Acetylsalicylic-acid | hsa05226 | Gastric cancer | 2.04E-03 | 3 | P31751, P04628, P10826 | AKT2, WNT1, RARB | More | | Acetylsalicylic-acid | hsa05230 | Central carbon metabolism in cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Acetylsalicylic-acid | hsa05231 | Choline metabolism in cancer | 2.02E-04 | 8 | P31751, P42338, O15245, Q9Y259, P19174, P49619, Q16760, O14986 | AKT2, PIK3CB, SLC22A1, CHKB, PLCG1, DGKG, DGKD, PIP5K1B | More | | Acetylsalicylic-acid | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.00E-09 | 14 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, P42224, O60603, P10747, Q04759, Q16539, Q9HC35, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, STAT1, TLR2, CD28, PRKCQ, MAPK14, EML4, CD4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q15131 | CDK10 | Cyclin-dependent kinase 10 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.791 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | P01106 | MYC | Myc proto-oncogene protein | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.834 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.762 | P01106 | MYC | Myc proto-oncogene protein | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.837 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.761 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.855 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.895 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.744 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P01106 | MYC | Myc proto-oncogene protein | P06239 | LCK | Tyrosine-protein kinase Lck | 0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.767 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.867 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.75 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q04759 | PRKCQ | Protein kinase C theta type | 0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P30304 | CDC25A | M-phase inducer phosphatase 1 | Q9HC35 | EML4 | Echinoderm microtubule-associated protein-like 4 | 0.737 | P01106 | MYC | Myc proto-oncogene protein | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.812 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P30304 | CDC25A | M-phase inducer phosphatase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.708 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.707 |
| Acetylsalicylic-acid | hsa05310 | Asthma | 6.83E-03 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Acetylsalicylic-acid | hsa05321 | Inflammatory bowel disease | 6.79E-06 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Acetylsalicylic-acid | hsa05322 | Systemic lupus erythematosus | 4.51E-02 | 6 | O75015, P08246, P08311, P01375, P10747, P13765 | FCGR3B, ELA2, CTSG, TNF, CD28, HLA-DOB | More | | Acetylsalicylic-acid | hsa05323 | Rheumatoid arthritis | 1.05E-03 | 5 | P01375, P13765, P10747, P09341, O60603 | TNF, HLA-DOB, CD28, CXCL1, TLR2 | More | | Acetylsalicylic-acid | hsa05330 | Allograft rejection | 2.83E-02 | 3 | P13765, P10747, P01375 | HLA-DOB, CD28, TNF | More | | Acetylsalicylic-acid | hsa05332 | Graft-versus-host disease | 5.77E-07 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Acetylsalicylic-acid | hsa05340 | Primary immunodeficiency | 2.67E-05 | 5 | P01730, P01732, P11912, P07766, P06239 | CD4, CD8A, CD79A, CD3E, LCK | More | | Acetylsalicylic-acid | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Acetylsalicylic-acid | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | | Acetylsalicylic-acid | hsa05418 | Fluid shear stress and atherosclerosis | 1.47E-06 | 11 | Q16539, P31751, P42338, Q14145, P10599, P14780, P01375, P04637, P14778, P27930, P0DP23 | MAPK14, AKT2, PIK3CB, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2, CALM1 | More | | |